DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
about
New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progressionAKR1C3 overexpression may serve as a promising biomarker for prostate cancer progressionThe rise of regulatory RNATwenty Years of PSA: From Prostate Antigen to Tumor MarkerPrevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortMolecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsProstate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerMEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspecklesPCGEM1, a prostate-specific gene, is overexpressed in prostate cancerBeyond the proteome: non-coding regulatory RNAsExpressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostateRNAdb--a comprehensive mammalian noncoding RNA databaseLncRNAs in pancreatic cancerPCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancerImmunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerPSA and beyond: alternative prostate cancer biomarkersNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismThe Clinical Relevance of Long Non-Coding RNAs in CancerGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsPotential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerLong Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic TargetsValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelLong non-coding RNAs and complex human diseasesUrinary biomarkers for prostate cancerActive surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypesNovel RNA markers in prostate cancer: functional considerations and clinical translationEmerging critical role of molecular testing in diagnostic genitourinary pathologyA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialDifferentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss.Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersHow Precisely Can Prostate Cancer Be Managed?Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaDiscovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyConservation and losses of non-coding RNAs in avian genomesMolecular markers in prostate cancer. Part I: predicting lethality.Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum.The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progressionMassively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA.Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool
P2860
Q21143810-1D3886A2-19E2-4FF9-AD58-741810573516Q21203668-5F0C67AF-5A4C-4E68-BB3D-595C5CACE5D5Q22121998-5FE274F1-1A7B-47BC-B186-5B64F7355DC0Q24564782-C6AF7348-5CEB-48C2-8874-10CAD57ACC67Q24606772-735FCA8F-C492-4EC3-9CE2-807E8336F434Q24629083-A8DC8D65-121F-4B2E-BDEF-EF907F9CC0CAQ24645528-BFE95D82-1396-4A94-8A6C-528A87F94ACEQ24651886-644A3BAF-71DC-420C-87EA-2212F565BDF7Q24682755-12B6EA44-BC26-4FAB-A3D2-5DD3340F0290Q24791802-E7ED7CE0-C894-4643-9582-04A31060AF67Q24793732-4F9494FC-1EC3-4F5A-B427-5ED8172DFE42Q24795939-FA48A349-9A07-4D3A-B0EC-61B43E1ECCD2Q26739965-FC4640B3-6E37-49B9-86FB-707EA4BF9B54Q26752933-178099BB-44BE-42F2-88E2-EDE47944DC6CQ26767044-CFAAD565-034B-448C-9866-F10C3FC929D1Q26770646-93139409-0A04-4046-8967-C357A7877EF8Q26774456-D70DECE5-AF3C-4697-A02B-79D2DB60015EQ26777757-F493A5B2-E0EC-44CC-A043-B47FF0C84524Q26778227-297C4198-09BE-49D0-AB95-07FF0CB46484Q26784517-E1F2BCC3-396A-4CBA-BCF9-F5666E7DDBC2Q26785935-0C362355-A2B5-40F1-AAF7-E51CA238BC87Q27001399-4FE5BEBD-598B-4E3A-BAF7-4D3AEC82A73FQ27004718-B7980E17-438D-4313-8CFF-6A5F876B46F0Q27009110-D0590293-3EAC-4463-AB5A-86163E5F5885Q27010695-2018CEFE-AAC0-42F5-8DAE-7F579CDD49B0Q27021174-BF6C6D91-1CDA-4CEB-8784-73D86241321FQ27021371-E6A12D7C-6C32-478E-9969-3316AF43DCF3Q27022638-F9FE3473-BA43-4E94-B97A-F390940DAE38Q27322590-07BB9BD4-0D5E-48BA-A465-52363FC555FAQ28075610-8AE940F1-A2AF-43C4-B6EC-8E356B6D827AQ28078942-1B49DEEC-BAAE-4FCB-8C43-935B72EC4906Q28085419-43603A68-32CE-4A06-BFE5-9E68F3DFBC17Q28534277-B42E6AC4-34CF-4229-A5A7-AC064A5CA807Q28651058-931D81BD-7EA0-490C-90D0-FFF2B0E7AD69Q30373669-939653E2-4F0E-4647-8E8F-8D3997031F2EQ30690776-6A5BB79E-92F3-4632-B73E-5B345CE301E1Q30878667-782251F1-A7F8-4FA7-A7D0-458EFDFEE7DBQ33372602-B9651869-41E0-445E-9E20-CAD9CE88A8CFQ33590048-3A8EC4DC-92E3-412A-9FC6-7E1A410C164AQ33728046-98B3EEA3-0F70-4082-9BD1-C7FA879334A7
P2860
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@ast
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@en
type
label
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@ast
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@en
prefLabel
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@ast
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@en
P2093
P1433
P1476
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
@en
P2093
Bussemakers MJ
Debruyne FM
Karthaus HF
Schalken JA
Verhaegh GW
van Bokhoven A
P304
P407
P577
1999-12-01T00:00:00Z